Science News

NEWCASTLE, England--(BUSINESS WIRE)--Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates (ADCs), will present new data from its Phase 1 study of IKS014, a human epidermal growth factor receptor 2 (HER2) ADC, in patients with advanced HER2+ solid tumours, at the European Society for Medical Oncology (ESMO) Congress in Berlin, Germany (17-21 October). Poster Presentation details: Abstract Title: A Phase 1 Dose Escalation Trial of IKS014, a HER2-Targeting Antibody...

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley today launched the AI Gateway, which brings trusted research content from scholarly publishers into leading AI tools through a single endpoint....

AMSTERDAM--(BUSINESS WIRE)--Giovanni Galliano joins Avanzanite Bioscience expanding Italian operations and initiating engagement with the Italian rare blood disorder community....

PARIS--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE:EL), under the High Patronage of Mr. Emmanuel Macron, President of the French Republic, today announced the opening of its Fragrance Atelier within its new La Maison des Parfums on Rue Volney in Paris. This newly established global innovation hub is fully dedicated to world-class fragrance expertise, advanced technologies and cutting-edge capabilities, and will accelerate the company’s strategic ambitions in luxury and prestige fragr...

BOSTON--(BUSINESS WIRE)--Foundation Medicine spotlights scientific achievements at ESMO Congress in 11 abstracts, including one oral presentation, across seven cancer types....

PHOENIX--(BUSINESS WIRE)--University of Phoenix College of Doctoral Studies announced a new white paper, “Autonomy and Competitive Edge: Mentorship as a Solution,” by Louise Underdahl, Ph.D., doctoral instructor and a research fellow with the University’s Center for Educational and Instructional Technology Research (CEITR), exploring how structured mentoring programs can help organizations address a growing crisis of worker autonomy, reduce burnout and improve retention. Drawing on findings fro...

AUSTIN, Texas--(BUSINESS WIRE)--Oticara Announces Positive Phase 2 Results Demonstrating Durable Symptom Improvement for Hard-to-Treat Post-Surgical Chronic Rhinosinusitis...

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced it will share initial topline safety, tolerability and early efficacy data from the Phase 1 LIONS trial in a poster presentation at the 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, being held October 22-26, 2025 in Boston, MA. The LIONS clinical trial (NCT06232408) is a first-...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that a late-breaking abstract (LBA) featuring new data from its global Phase 1 clinical trial (NCT06179069) evaluating zocilurtatug pelitecan (zoci), formerly known as ZL-1310, has been selected for an oral presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place October 22-26, 2025, in Boston, Massachusetts. The presentation will...

BOSTON--(BUSINESS WIRE)--eClinical Solutions LLC, a global provider of digital clinical software and services, today announced two major recognitions from the Society for Clinical Data Management (SCDM), highlighting the company’s leadership in advancing data science innovation. At the 2025 SCDM Annual Conference, elluminate Assist, a generative AI-powered assistant built within eClinical Solutions’ elluminate Clinical Data Cloud®, was awarded the SCDM Innovation Award for “Advancements in Heal...